Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
117.75
+2.49 (2.16%)
At close: Sep 11, 2026
NSE:GAUDIUMIVF Revenue
Gaudium IVF and Women Health had revenue of 193.77M INR in the quarter ending June 30, 2026, a decrease of -28.03%. This brings the company's revenue in the last twelve months to 1.06B, up 49.85% year-over-year. In the fiscal year ending March 31, 2026, Gaudium IVF and Women Health had annual revenue of 1.04B with 47.56% growth.
Revenue (ttm)
1.06B
Revenue Growth
+49.85%
P/S Ratio
8.09
Revenue / Employee
8.83M
Employees
n/a
Market Cap
8.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04B | 336.33M | 47.56% |
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indraprastha Medical Corporation | 15.24B |
| Shalby | 11.76B |
| Artemis Medicare Services | 11.14B |
| Nephrocare Health Services | 10.54B |
| Jeena Sikho Lifecare | 8.51B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |
| Unihealth Hospitals | 1.32B |